Bill > SB702

This bill proposes to add a new chapter to Pennsylvania's health and safety laws that prohibits healthcare providers from using telemedicine (remote medical consultations) to prescribe medications that are subject to a Risk Evaluation and Mitigation Strategy (REMS) administered by the U.S. Food and Drug Administration. The bill defines key terms such as "health care facility," "health care provider," and "telemedicine" by referencing existing legal definitions, and specifically targets medications with special safety protocols that require additional monitoring and management. The REMS program typically applies to drugs that may have serious safety concerns or require specific patient management strategies. By preventing telemedicine prescriptions for these medications, the bill aims to ensure that patients receive in-person medical evaluation and monitoring for potentially high-risk medications. The new law would take effect 60 days after its passage, giving healthcare providers time to adjust their practices to comply with the new restrictions.

Health and Social Services

https://www.legis.state.pa.us/cfdocs/billinfo/bill_history.cfm?syear=2025&sind=0&body=S&type=B&bn=702